|
KHDRBS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.320200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.290200E-02 |
| Normal-vs-Stage2 |
5.738200E-03 |
| Normal-vs-Stage3 |
3.582200E-03 |
| Normal-vs-Stage4 |
5.004500E-04 |
| Stage1-vs-Stage2 |
1.370630E-01 |
| Stage1-vs-Stage3 |
2.534800E-01 |
| Stage1-vs-Stage4 |
5.166000E-02 |
| Stage2-vs-Stage3 |
5.358400E-01 |
| Stage2-vs-Stage4 |
9.529400E-01 |
| Stage3-vs-Stage4 |
4.801600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.784200E-03 |
| Normal-vs-AfricanAmerican |
7.393000E-01 |
| Normal-vs-Asian |
1.011000E-01 |
| Caucasian-vs-AfricanAmerican |
3.814000E-02 |
| Caucasian-vs-Asian |
5.328200E-01 |
| AfricanAmerican-vs-Asian |
1.435770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.459800E-03 |
| Normal-vs-Female |
4.660100E-03 |
| Male-vs-Female |
5.852600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.340200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.659810E-03 |
| Normal-vs-Age(61-80Yrs) |
3.014200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.647360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.459700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.023600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.749800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.379400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.064000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.233400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.827770E-01 |
| Classical-VS-Follicular |
1.199900E-04 |
| Classical-VS-Other |
3.133000E-01 |
| Classical-VS-Normal |
1.930240E-01 |
| Tall-VS-Follicular |
9.623700E-02 |
| Tall-VS-Other |
7.590000E-01 |
| Tall-VS-Normal |
3.009600E-02 |
| Follicular-VS-Other |
6.416800E-01 |
| Follicular-VS-Normal |
3.98310000000457E-05 |
| Other-VS-Normal |
1.323620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.381800E-04 |
| Normal-vs-N1 |
2.197100E-03 |
| N0-vs-N1 |
7.878800E-01 |
|
|
